Atrium Therapeutics gets FDA clearance for ATR 1072 IND application
Atrium Therapeutics announced on July 14, 2026 that the FDA has cleared its Investigational New Drug application for ATR 1072, allowing the company to begin its…
Company
SEC filing news and material events for Atrium Therapeutics, Inc., briefed from primary-source filings.
1 story
Atrium Therapeutics announced on July 14, 2026 that the FDA has cleared its Investigational New Drug application for ATR 1072, allowing the company to begin its…